341 filings
Page 4 of 18
6-K
EVGN
Evogene Ltd
26 Jul 22
Biomica Announces First Patient Dosed in its Phase I Study of its
7:01am
6-K
EVGN
Evogene Ltd
14 Jul 22
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
7:01am
6-K
EVGN
Evogene Ltd
11 Jul 22
Biomica Announces Successful Enrollment of First Patient in its Phase I
7:00am
6-K
EVGN
Evogene Ltd
31 May 22
Current report (foreign)
7:00am
6-K
EVGN
Evogene Ltd
26 May 22
Evogene Reports First Quarter 2022 Financial Results
7:00am
6-K
EVGN
Evogene Ltd
26 Apr 22
Current report (foreign)
7:00am
424B3
EVGN
Evogene Ltd
31 Mar 22
Prospectus supplement
5:28pm
20-F
2021 FY
EVGN
Evogene Ltd
Annual report (foreign)
31 Mar 22
5:00pm
6-K
EVGN
Evogene Ltd
23 Mar 22
Current report (foreign)
8:00am
6-K
EVGN
Evogene Ltd
10 Mar 22
Evogene Reports Fourth Quarter and Full Year 2021 Financial Results
7:00am
6-K
EVGN
Evogene Ltd
14 Feb 22
Current report (foreign)
7:00am
SC 13G/A
EVGN
Evogene Ltd
11 Feb 22
Evogene / MACQUARIE ownership change
12:15pm
SC 13G/A
EVGN
Evogene Ltd
9 Feb 22
Evogene / ARK Investment Management ownership change
2:35pm
6-K
EVGN
Evogene Ltd
2 Feb 22
Current report (foreign)
7:15am
6-K
EVGN
Evogene Ltd
18 Jan 22
Canonic Announces Positive Results in Pre-Clinical Studies in its
7:00am
6-K
EVGN
Evogene Ltd
11 Jan 22
Biomica Announces Clearance for First-in-Human Phase I
7:00am
6-K
EVGN
Evogene Ltd
10 Jan 22
Current report (foreign)
7:00am
6-K
EVGN
Evogene Ltd
3 Jan 22
Current report (foreign)
7:01am
6-K
EVGN
Evogene Ltd
14 Dec 21
Advancement to the pre-commercial stage follows positive results from three consecutive
7:00am
6-K
EVGN
Evogene Ltd
30 Nov 21
Biomica Reports Positive Results from Pre-Clinical Studies in its
7:00am